Stay updated on Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.4, replacing the previous Revision: v3.3.3; this is a minor UI/metadata update with no impact on study content — To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:40:11.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Locations section reorganized to consolidate Florida, Indiana, and Ohio under a single 'Locations' heading, replacing separate 'Florida Locations', 'Indiana Locations', and 'Ohio Locations' entries. The page revision updated to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T20:54:20.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed and may not all relate to the study, and updated the revision to v3.3.2. Removed the earlier PubMed publications note referencing revision v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T11:37:37.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A government funding status notice was removed from the page. This is a non-significant housekeeping update that does not affect study details or participation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:14:51.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Screenshots show only minor administrative updates to the page layout and recent update timestamps; no core study content such as eligibility criteria, endpoints, or locations appears added or removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:05:36.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    Significant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 tag removed. Core content impacted by the new status information.
    Difference
    2%
    Check dated 2025-10-06T05:49:29.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.